I recently had the pleasure of interviewing Trey Crabb, Founder and President of Health Strategy Partners, LLC, located in Nashville. Trey is a veteran strategic and financial advisor to the healthcare industry. In 2010, Trey founded Health Strategy Partners after … Continue Reading
In our January 4th blog post we discussed the results of two studies indicating venture capitalists were regaining confidence in various industries and are expected to invest more in 2011 but with some hesitation surrounding medical device companies. Data released on … Continue Reading
As we’d previously reported, the U.S. House had scheduled to vote today on legislation repealing in full the healthcare reform law known as The Affordable Care Act (aka PPACA). In response to the shootings of Arizona Congresswoman Gabrielle Giffords and others this past … Continue Reading
According to at least two recently published surveys, the answer is yes.
National Venture Capital Association/Dow Jones Venture Source Survey
With the mid-term elections now behind us and the Republicans faring as successfully as generally predicted, all segments of the healthcare industry are looking closely at what the new Congressional power balance will mean for them. With several seats still in … Continue Reading
With ACOs as such a hot topic right now, and the variety of forms these organizations can take, healthcare investors can examine not only opportunities in ACOs themselves but in healthcare related businesses that will service or be affiliated … Continue Reading
With the authorization of Accountable Care Organizations (ACOs) in the healthcare reform law (PPACA), there has been a tremendous amount of industry attention on understanding ACOs and the opportunities and challenges they present. With ACOs as such a hot topic … Continue Reading
McGuireWoods has announced its Second Annual Medical Device, Durable Medical Equipment & Diagnostics Conference to be held on November 3rd in Deerfield, Illinois just outside of Chicago. Medical device manufacturer and distributor managers, compliance officers, investors in medical device manufacturers … Continue Reading
The Centers for Medicare & Medicaid Services (CMS) conducts and sponsors a number of demonstration projects to test and measure the effect of potential program changes. These demonstration projects study the likely impact of new methods of service delivery, coverage of … Continue Reading
Krist Werling was interviewed by Becker’s Orthopedic and Spine Review on current trends and issues for orthopedic and spinal device manufacturers. The interview addresses a wide variety of issues for ortho and spine manufacturers including the impact of healthcare reform … Continue Reading
In two prior posts regarding, we addressed various questions for a seller to consider when selecting an investment bank to help the seller achieve its transaction goals. Those questions, as well as those below, are just a handful of questions … Continue Reading
As a follow-up to our prior post on the topic, below are a few key additional questions that sellers can consider when evaluating investment banks in order to find the bank that will ultimately meet the sellers’ needs. These questions are excerpted … Continue Reading
This blog post is the second in a series examining the potential impact of health reform on medical device companies. The first post can be accessed here.
1. Payment Reductions. The Healthcare Reform Act did not include direct … Continue Reading
As investors consider potential investments, it is important to take into account the future impact of the recently passed health reform legislation. This blog post is part I of an itemization of 10 areas of the health reform bill that will likely … Continue Reading
We recently had the opportunity to travel with Amsino International to visit several of Amsino’s medical device manufacturing facilities located in and around Shanghai, China. The experience prompted two key observations regarding the global health care system and its impact on … Continue Reading
Now more than ever, it is critical that anyone contemplating investment in a healthcare sector carefully review the target company’s compliance protocols. We have always strongly recommended that investors analyze the company’s compliance program, as well as efforts at adhering to … Continue Reading
On April 6th, US-based biopharmaceutical company Cephalon, Inc. (NASDAQ: CEPH) acquired all of the outstanding capital stock of Ception Therapeutics, Inc., also a US-based biopharmaceutical company focused on developing novel products to address areas of unmet medical … Continue Reading
The Patient Protection and Affordable Healthcare Act (commonly known as the "healthcare reform" bill) includes significant new transparency and disclosure obligations that apply to physicians, hospitals, and medical device and pharmaceutical manufacturers.
Some of these transparency and disclosure obligations are … Continue Reading
The healthcare sector saw a significant decrease in the number of private equity transactions completed last year. Pitchbook reported that approximately 125 deals were completed where private equity funds invested in healthcare companies in 2009. This is down from 233 … Continue Reading
Will healthcare reform help or hurt medical device and medical manufacturers? That is the question on many device managers’ and shareholders’ minds. At first blush, many stakeholders assume that healthcare reform will drive down margins and include new regulations that … Continue Reading